%0 Journal Article
%@ 2369-3762
%I JMIR Publications
%V 9
%N 
%P e48586
%T The Impact of Web-Based Continuing Medical Education Using Patient Simulation on Real-World Treatment Selection in Type 2 Diabetes: Retrospective Case-Control Analysis
%A Lucero,Katie Stringer
%A Larkin,Amy
%A Zakharkin,Stanislav
%A Wysham,Carol
%A Anderson,John
%+ Medscape, LLC, 395 Hudson St, New York, NY, 10014, United States, 1 212 301 6782, klucero@webmd.net
%K continuing medical education
%K virtual patient simulation
%K real-world evidence
%K evaluation
%K outcomes
%K diabetes education
%K medical education
%K type 2 diabetes
%K web-based learning
%K web-based education
%D 2023
%7 29.8.2023
%9 Original Paper
%J JMIR Med Educ
%G English
%X Background: Despite guidelines recommending the use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) in certain patients with type 2 diabetes (T2D), they are not being prescribed for many of these patients. Web-based continuing medical education (CME) patient simulations have been used to identify clinicians’ practice gaps and improve clinical decision-making as measured within a simulation, but the impact of this format on real-world treatment has not been researched. Objective: This study aimed to evaluate the effect of a simulation-based CME intervention on real-world use of GLP-1 RAs by endocrinologists and primary care physicians. Methods: Two evaluation phases of the CME simulation were conducted: phase I, the CME simulation phase, was a paired, pre-post study of 435 physician learners in the United States; and phase II, the real-world phase, was a retrospective, matched case-control study of 157 of the 435 physicians who had claims data available for the study period. Results: Phase I CME results showed a 29 percentage point increase in correct decisions from pre- to postfeedback (178/435, 40.9% to 304/435, 69.9%; P<.001) in selecting treatment that addresses both glycemic control and cardiovascular event protection. Phase II results showed that 39 of 157 (24.8%) physicians in the intervention group increased use of GLP-1 RAs, compared to 20 of 157 (12.7%) in the comparison group. Being in the intervention group predicted GLP-1 RA use after education (odds ratio 4.49; 95% CI 1.45-13.97; P=.001). Conclusions: A web-based CME simulation focused on secondary prevention of cardiovascular events in a patient with T2D was associated with increased use of evidence-based treatment selection in the real world. 
%M 37642994
%R 10.2196/48586
%U https://mededu.jmir.org/2023/1/e48586
%U https://doi.org/10.2196/48586
%U http://www.ncbi.nlm.nih.gov/pubmed/37642994